A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.

Tom Nolan reviews this week’s research Microplastics and nanoplastics (MNPs) are being found just about everywhere we look, and they have now been found in our brains. A report in Nature Medicine ...

The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...